84. サルコイドーシス Sarcoidosis Clinical trials / Disease details
臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03561025 (ClinicalTrials.gov) | October 1, 2018 | 6/6/2018 | Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis | Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis: A Pilot Study Combining Advanced MRI and 18F-FDG and 18F-GE180 PET of the Myocardium | Sarcoidosis;Cardiomyopathies | Diagnostic Test: 18F-FDG-PET/MRI;Diagnostic Test: 18F-GE180-PET/MRI | St. Olavs Hospital | Norwegian University of Science and Technology;University Hospital, Essen | Completed | 18 Years | N/A | All | 33 | N/A | Norway |
2 | NCT03705884 (ClinicalTrials.gov) | January 1, 2018 | 8/8/2018 | PET/MR Imaging In Patients With Cardiac Sarcoidosis | Molecular Imaging in Cardiovascular Disease Using Hybrid Positron Emission Tomography/Magnetic Resonance Imaging (PET/MR): Cardiac Sarcoidosis | Cardiac Sarcoidosis | Other: 18F-FDG;Drug: Prednisolone | University of Edinburgh | NULL | Unknown status | 40 Years | N/A | All | 40 | N/A | United Kingdom |
3 | NCT03356756 (ClinicalTrials.gov) | June 27, 2016 | 3/11/2017 | PET MRI Study in Patients With Cardiac Sarcoidosis | Diagnostic and Prognostic Significance of Combined PET/MRI in Inflammatory Cardiomyopathies and Sarcoidosis | Inflammatory Cardiomyopathy;Sarcoidosis | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | University Health Network, Toronto | NULL | Recruiting | 18 Years | N/A | All | 60 | Canada | |
4 | NCT01764191 (ClinicalTrials.gov) | January 1, 2012 | 3/1/2013 | 18F-FDG PET Imaging in Cardiac Sarcoidosis | [18 F]-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET) in Cardiac Sarcoidosis | Cardiac Sarcoidosis | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | British Columbia Cancer Agency | NULL | Approved for marketing | 19 Years | N/A | All | Canada | ||
5 | JPRN-UMIN000004267 | 2010/10/01 | 01/10/2010 | PET/CT finding of cardiac sarcoidosis | sarcoidosis | Give heparin Na before 18F-FDG PET/CT in the diagnosis of cardial sarcoidosis. | Tokushima University Hospital | NULL | Pending | Not applicable | Not applicable | Male and Female | 30 | Not selected | Japan |